Superpower

What Superpower does

Superpower Health, Inc. is a San Francisco-based preventive health platform founded in early 2023 by Max Marchione, Jacob Peters, and Kevin Unkrich. The company offers a $199/year annual membership (reduced from $499 in August 2025) that bundles a single 10-minute blood draw at 2,000+ Quest Diagnostics partner labs across 40+ US states covering 100+ biomarkers, a proprietary AI layer (Superpower AI) that ingests lab results, uploaded past labs, wearable data (Oura, Whoop, Apple Health), and the member's goals, and a 24/7 clinician care team that together produce a personalized health protocol. Add-on products include a +34 Advanced biomarker panel, specialty panels (e.g., Fertility, Autoimmune), the Organ Age Panel (nine system-specific biological age scores), and marketplace integrations such as GRAIL's Galleri multi-cancer screen, Tiny Health microbiome testing, and the Tetratherix-licensed STEPP needle-free nasal delivery technology for GLP-1s, peptides, and hormones.

The business model is anchored on the annual subscription (with the US-only geography constrained at present) and supplemented by specialty-panel add-on pricing, marketplace commissions on partner supplements, employer-benefits distribution via Stratos Health, a $49/year bundled membership through Prenetics' IM8 subscribers, and licensing/R&D payments from technology partners such as Tetratherix (US$3M/year, up to 10 years). The customer base is dominated by health-conscious individual consumers across 40+ US states, with secondary segments in B2B employer benefits (Stratos), women (hormonal and reproductive health, strengthened by the Feminade acquisition), and performance-focused athletes and celebrities backed by investor-endorsers Giannis Antetokounmpo, Steve Aoki, and Vanessa Hudgens. Distribution combines a self-serve e-commerce storefront, an iOS app, B2B channel partners, embedded partner bundles, and event activations (SoulCycle Fall Challenge, Peptide Friday).

By early 2026 the company had raised more than $42M in total venture funding (including a $30M Series A led by Forerunner in April 2025 and a $4M Susa Ventures-led pre-seed in May 2024), converted a 150,000-person pre-launch waitlist, and reported 1M+ biomarkers tested across its member base. Active operational headcount is reported in the 11–50 range with ongoing hiring advertised on the careers page. The company is navigating a January 2026 false-advertising lawsuit filed by competitor Function Health in U.S. District Court (Central District of California) that contests the '100+ biomarkers' marketing claim, representing a material reputational and regulatory headwind.

Name

Superpower

Legal name

Superpower Health, Inc.

Website

https://superpower.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Superpower Health, Inc. is a San Francisco-based preventive health platform offering a $199/year membership that combines a 100+ biomarker blood panel through Quest Diagnostics, an AI-driven personalized protocol, 24/7 clinician access, and add-on specialty tests for U.S. health-conscious consumers, employers, and women's-health segments.

Ownership category

akta.pro rank

Product category

Preventive Health Diagnostics

NAICS

Health and Personal Care Retailers (456)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Membership/Subscription Concierge Virtual Care (HLALAAAH)

Keywords

• Preventive health diagnostics
• Biomarker blood testing
• Longevity medicine platform
• AI health protocol
• Digital health membership

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Annual Membership Subscription: Core $199/year membership (down from $499 in August 2025) provides annual 100+ biomarker testing, AI guidance, 24/7 care team, digital dashboard, wearable sync, and marketplace access. HSA/FSA eligible, billed annually, cancel anytime. NY/NJ priced higher at $399.
2. Specialty Panel Add-Ons: Discrete specialty blood panels sold separately, e.g., the Fertility Panel priced $159–$229 across the U.S. as part of the Specialty Panels expansion following the Feminade acquisition.
3. Licensing & R&D Payments from Technology Partners: Long-term licensing and R&D arrangement with Tetratherix (US$3 million/year for up to 10 years) for the STEPP needle-free nasal delivery technology applied to GLP-1s, peptides, and hormones.
4. B2B Employer Benefits Channel: Revenue from employer/benefits distribution partnerships such as Stratos Health, which integrates Superpower into employee wellness programs at zero cost to the employee.
5. Marketplace Commissions on Partner Supplements: Marketplace commissions when members purchase partner-supplied clinical-grade supplements (e.g., IM8 Daily Ultimate Essentials featured inside Superpower's personalized protocols).
6. Peptide Sales and Future Clinical Trials: Sale of legally available peptides to members (the company plans to develop proprietary peptides and fund clinical trials amid shifting FDA compounding rules).

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels9 records

Core offering

Superpower sells an annual membership that bundles a 100+ biomarker blood test (drawn at 2,000+ Quest Diagnostics partner labs or via at-home phlebotomy) with an AI-driven personalized health protocol, 24/7 clinician care-team access, wearable integrations (Oura, Whoop, Apple Health), and a curated marketplace of add-on tests, peptides, supplements, and prescriptions. The membership is priced at $199/year (most US) or $399/year (NY/NJ), HSA/FSA eligible, with specialty add-on panels (e.g., Fertility Panel $159–$229) and partnership bundles (IM8 at $49/year) expanding the offering.

Product overview

Superpower is a single unified consumer health platform — anchored by its $199/year Superpower Membership — that combines a 100+ biomarker Baseline blood panel (with an Advanced +34 upgrade and numerous Specialty Panels such as the Fertility Panel and Organ Age Panel) with a personalized AI protocol, 24/7 care-team access, wearable integrations (Oura, WHOOP, Apple Health), and a curated Marketplace of add-on tests (e.g., GRAIL's Galleri cancer screen, Tiny Health microbiome, Tetratherix STEPP-enabled nasal peptides/GLP-1s), supplements, and prescriptions. Built atop CLIA-certified, CAP-accredited labs (Quest Diagnostics for blood draws), the platform layers three product pillars — Superpower AI (generative, retrieval-grounded assistant), the Superpower Care Team (human clinicians), and the Superpower Marketplace (Reviewed-by-Superpower-Research-Team offerings) — and extends to employers via Superpower for Organizations. The portfolio is rounded out by acquired sub-brands Feminade (women's hormonal health) and Base (biomarker tracking), plus an iOS companion app.

Differentiator

Problem solved

Functional benefit

Products and services

• Superpower Membership Flagship annual subscription that bundles the 100+ biomarker blood panel, AI-driven personalized health protocol, 24/7 clinician care-team access, wearable sync (Oura, Whoop, Apple Health), upload of past labs and medical records, and add-on marketplace access. Priced at $199/year ($399/year in NY/NJ), HSA/FSA eligible, cancel anytime.
• Baseline Panel (100+ biomarkers) Default 100+ biomarker blood panel covering heart & vascular (26), metabolic (34), inflammation (15), immune (15), kidney (16), liver (16), nutrients (19), sex hormones (9), thyroid (9), DNA health (2), energy (5), gut health (5), and brain health (7) categories from a single 10-minute blood draw.
• Advanced Panel (+34 biomarkers) Expansion of the Baseline Panel with an additional 34 biomarkers including erythrocyte sedimentation rate, fasting insulin, C-peptide, fructosamine, adiponectin, leptin, methylmalonic acid, vitamin B6, oxidized LDL, ADMA/SDMA, cystatin C, and others.
• Organ Age Panel Composite aging metrics covering Cognitive, Nervous, Musculoskeletal, Digestive, Circulatory, Metabolic, Infectious, Genitourinary, and Respiratory organ systems, plus an overall BioAge, Pace of Aging, and Health Score.
• Fertility Panel (Specialty Panels) Specialty reproductive-health blood panel priced $159–$229 across the U.S., introduced alongside the Specialty Panels rollout to extend Superpower into hormonal/fertility testing.
• Superpower AI Always-on AI assistant informed by the member's biomarker results, uploaded past labs, medical records, wearable data, and current protocol. Answers clinical-context questions, clarifies biomarkers, explains protocol items, and adjusts timing/dosage within clinical guardrails.
• Superpower Care Team (24/7) On-demand private care team available 24/7 for questions that go beyond AI guidance or need deeper clinician review, with full context preserved across hand-offs so members don't repeat themselves.
• Superpower Marketplace (add-on tests, peptides, supplements, prescriptions) Curated add-on offerings accessible to members, including additional tests (e.g., Galleri cancer screen, gut, toxins), peptides, supplements, and prescription access. Items carry the "Reviewed by the Superpower Research Team" trust seal based on the company's five-step review process.
• Superpower App (iOS) Companion iOS application that gives members on-the-go access to their biomarker dashboard, AI chat, care team, and marketplace.
• Superpower for Organizations (B2B / employer offering) B2B extension of Superpower's preventive platform (e.g., zero-cost employee benefit via Stratos Health), giving employers access to advanced diagnostics and personalized health planning for their workforce.
• Feminade (acquired women's hormonal health sub-brand) Women's hormonal-health testing and solutions platform acquired in January 2025; its capabilities now feed Superpower's Specialty Panels (e.g., Fertility Panel, Extended Women's Health).
• Base (acquired biomarker-tracking sub-brand) Biomarker-tracking product acquired alongside Feminade to expand the Superpower App's tracking surface area and power the AI doctor app.

Quantifiable outcome

• 60% of members identify a health issue previously missed or overlooked by a doctor
• +6 more outcomes

Named customers13 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability11 records

Feature6 records

Partnerships

15 partnerships are on record, tiered flagship cancer-screening partner, flagship supplements + closed-loop partner, major r&d and licensing partner, mid-tier activation partner, major employer-benefits distribution partner, major celebrity backer & referral program driver, celebrity backer, microbiome b2b integration partner, core lab fulfillment partner, brand-credibility affiliations, senior clinical leader, medical advisory board and medical advisory board + nationwide medical network.

• GRAIL, Inc.flagship cancer-screening partnerStrategic or Co-development Partner · 1 April 2026Strategic partnership announced April 2026 integrating GRAIL's Galleri multi-cancer early detection blood test into Superpower's preventive health platform. Galleri can detect signals from over 50 cancer types; PATHFINDER 2 study showed adding Galleri to standard screenings increased cancer detection more than seven-fold. The partnership also addresses the rise of early-onset cancers (up ~80% globally since 1990).
• Prenetics Global / IM8flagship supplements + closed-loop partnerStrategic or Co-development Partner · 24 March 2026Strategic partnership creating a closed-loop system: IM8 90-day subscribers access Superpower's annual 100+ biomarker testing for $49/year (75% off the $199 list); IM8's Daily Ultimate Essentials is featured in Superpower's marketplace. IM8 had reached $100M+ annualized recurring revenue within 11 months.
• Tetratherix (ASX: TTX)major r&d and licensing partnerStrategic or Co-development Partner · 16 March 2026Exclusive 10-year R&D and licensing agreement in which Superpower Health Inc. purchases Tetratherix's STEPP needle-free nasal delivery technology for GLP-1s, peptides, and hormones in the U.S. market. Tetratherix receives US$3 million in annual license payments (up to US$30M over 10 years).
• SoulCyclemid-tier activation partnerGTM or Marketing Partner · 7 October 2025Partnership integrating Superpower's biomarker testing into SoulCycle's Fall Challenge, allowing participants to track over 100 health metrics during high-intensity cycling sessions.
• Stratos Healthmajor employer-benefits distribution partnerChannel Partner/ Reseller/ Distributor · 24 September 2025Partnership to deliver comprehensive wellness and preventive care services — including advanced diagnostics and personalized health planning — to employers and employees at no cost through Stratos' benefits framework.
• Giannis Antetokounmpo (NBA)major celebrity backer & referral program driverGTM or Marketing PartnerNBA champion listed as a participating investor in the Series A round and featured in an on-site referral giveaway ('Your friend wants to meet Giannis Antetokounmpo').
• Steve Aoki (DJ)celebrity backerGTM or Marketing PartnerDJ Steve Aoki listed as a participating investor and cultural backer of Superpower, featured in press coverage of the Series A and $199 launch.
• Vanessa Hudgens (actress)celebrity backerGTM or Marketing PartnerActress Vanessa Hudgens listed as a participating investor and cultural backer of Superpower, referenced in Series A and $199 launch coverage.
• Tiny Healthmicrobiome b2b integration partnerTechnology or IntegrationTiny Health's microbiome testing is integrated into Superpower's preventive care models via the Powered by Tiny B2B platform, alongside Mayo Clinic Executive and Longevity Programs, Pritikin Longevity Center, Mito Health, Tastermonial, and ProteusDx.
• Quest Diagnosticscore lab fulfillment partnerTechnology or IntegrationLab draw services fulfilled at 2,000+ Quest Diagnostics partner labs across 40+ US states; Quest is the primary lab partner powering Superpower's 100+ biomarker panel.
• Stanford, Harvard, Oxford (Medical Advisory Board institutions)brand-credibility affiliationsOthersBrand affiliations featured on the homepage hero and Medical Advisory Board section to signal clinical rigor; clinicians from these institutions (and UCLA) sit on the advisory board.
• Dr. Anant Vinjamoori (Chief Longevity Officer)senior clinical leaderOthersBoard-certified longevity physician; previously product leader at Virta Health ($3B valuation) and CMO at Modern Age; leads clinical strategy at Superpower and runs Next Generation Medicine training clinicians in advanced longevity protocols.
• Dr. Leigh Erin Connealy (Center for New Medicine)medical advisory boardOthersIntegrative medicine physician with ~40 years of experience; founded Center for New Medicine in 1992 and Cancer Center for Healing in 2009; leads the largest integrative medical clinic in North America (>47,000 patients treated).
• Dr. Robert Lufkin (UCLA / USC)medical advisory boardOthersUCLA Medical School professor, NYT bestselling author of 'Lies I Taught in Medical School'; author of 200+ peer-reviewed papers and 14 books; featured on The Today Show, USA Today, and FOX.
• Dr. Abe Malkin (Concierge MD / Drip Hydration)medical advisory board + nationwide medical networkOthersFounder & Medical Director of Concierge MD (nationwide concierge practice) and Drip Hydration (mobile IV therapy in 100+ cities); leads Wellness MD Group; serves as medical director for several addiction treatment centers.

Scale indicators10 records

Recent moves6 records

Expansion highlights8 records

Direct peers

• Function Health: Function Health is a direct-to-consumer preventive health platform offering 100+ biomarker blood testing plus AI-driven insights on a $365/year annual membership. It is Superpower's most direct head-to-head competitor, the plaintiff in the active false-advertising lawsuit, and the company Superpower explicitly benchmarks against in its comparison pages.
• Mito Health: Mito Health provides comprehensive blood biomarker testing with clinician-led insights and longevity-focused protocols, often positioned as a premium concierge-style offering. It is a direct peer targeted in Superpower's /superpower-vs-mito-health comparison page and is also a Tiny Health 'Powered by Tiny' partner alongside Superpower.
• InsideTracker: InsideTracker offers personalized blood-based biomarker testing with AI-driven nutrition and lifestyle recommendations, including a longevity-focused 'InnerAge' metric. It targets the same health-conscious, performance- and longevity-oriented consumer segment as Superpower and is featured in Superpower's /superpower-vs-insidetracker comparison page.
• Viome Life Sciences: Viome sells direct-to-consumer gut microbiome and blood-based RNA testing with AI-personalized nutrition and supplement recommendations. It targets the same preventive-health/longevity consumer, offers a similar 'test → personalized protocol → supplement' closed loop, and competes with Superpower in the marketplace and microbiome spaces (Superpower partners with Tiny Health for microbiome).
• Thorne HealthTech: Thorne is a clinical-grade supplements and at-home health testing brand (now part of L Catterton-owned parent) with overlapping offerings across biomarker testing, supplements, and personalized health protocols. It directly competes with Superpower's marketplace and supplement recommendations, and is a well-known brand in the same consumer longevity category.
• Marek Health: Marek Health provides direct-to-consumer blood testing, hormone optimization, and personalized health protocols, particularly for performance and longevity-focused men. It is a direct competitor in the blood-panel-plus-personalized-protocol category that Superpower occupies.

Broad incumbents

• Human Longevity Inc. Human Longevity Inc. (founded by Craig Venter) is an early mover in the comprehensive preventive health and longevity space, offering whole-genome sequencing, full-body MRI, and advanced biomarker panels through premium concierge programs. It operates at a much higher price point than Superpower and serves a smaller, wealthier clientele, but is a comparable category-defining incumbent.

Emerging players

• Zoe: Zoe is a consumer nutrition science company offering at-home blood and microbiome testing combined with personalized diet scores and AI-driven nutrition recommendations. It targets the same health-conscious, data-driven consumer segment as Superpower and represents a comparable 'test + AI protocol' preventive health business model.
• GRAIL: GRAIL's Galleri test is a multi-cancer early-detection blood test integrated into the Superpower platform as a strategic partnership. GRAIL is also a partial-overlap peer — both companies pursue early-detection blood-based diagnostics for proactive health, but GRAIL specializes in oncology signal detection rather than broad biomarker panels.
• Prenetics Global: Prenetics is a genetics and preventive health company that operates the IM8 supplements brand, with which Superpower has a strategic closed-loop partnership (IM8 subscribers get Superpower at $49/year). Prenetics is a partner-distribution channel for Superpower and a comparable DNA/microbiome/preventive-testing peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/superpower
• LinkedInlinkedin.com/company/superpower-health
• Instagraminstagram.com/superpower

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries2 records

Funding overview

Funding rounds4 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Superpower